An Innovative Surgical Technique for Subretinal Transplantation of Human Embryonic Stem Cell-Derived Retinal Pigmented Epithelium in Yucatan Mini Pigs: Preliminary Results
Authors:
- Rodrigo A. Brant FernandesRFRodrigo A. Brant Fernandes
- Michael Janusz KossMKMichael Janusz Koss
- Paulo FalabellaPFPaulo Falabella
- Francisco Rosa StefaniniFSFrancisco Rosa Stefanini
- Mauricio MaiaMMMauricio Maia
- Bruno DinizBDBruno Diniz
- Ramiro RibeiroRRRamiro Ribeiro
- Yuntao HuYHYuntao Hu
- David HintonDHDavid Hinton
- Dennis O. CleggDCDennis O. Clegg
- Gerald ChaderGCGerald Chader
- Mark S. HumayunMHMark S. Humayun
Open Access
- 1 April 2016
- journal article
- Published by SLACK, Inc. in Ophthalmic Surgery, Lasers and Imaging Retina
- Vol. 47 (4) , 342-351
Abstract
BACKGROUND AND OBJECTIVE: To develop a safe and efficient surgical procedure for subretinal implantation into porcine eyes of a human embryonic stem cell-derived retinal pigmented epithelium (hESC-RPE) monolayer seeded onto a Parylene-C scaffold. This implant is referred to as CPCB-RPE1. MATERIALS AND METHODS: Ultrathin Parylene-C scaffolds were seeded with hESC-RPE and surgically implanted into the subretinal space of Yucatan mini pigs (n = 8). The surgery consisted of pars plana vitrectomy, induction of a limited retinal detachment, and peripheral retinotomy for insertion of the monolayer using a novel tissue injector, followed by silicone oil tamponade injection, laser photocoagulation around the retinotomy site, and inferior iridectomy. Oral cyclosporine was administered from day 1 and during the entire follow-up period. Three months later, the animals were euthanized and the eyes and major organs were submitted for histological analysis. Adjacent sections underwent immunohistochemical analysis to detect human cells using anti-TRA-1-85 (human blood group antigen) antibody and DAPI antibodies. RESULTS: The cell monolayer was immunopositive for TRA-1-85 3 months after implantation and migration from the Parylene-C scaffold was not detected. One eye had a mild inflammatory reaction around the implant that was negative for human biomarkers. No intraocular or systemic tumors were detected. CONCLUSION: The hESC-RPE cells survived for 3 months in this animal model. The surgical procedure for subretinal implantation of CPCB-RPE1 is feasible and safe, without cell migration off the scaffold or development of ocular or systemic tumors. [ Ophthalmic Surg Lasers Imaging Retina . 2016;47:342–351.]Keywords
This publication has 25 references indexed in Scilit:
- Imaging of the Retinal Pigment Epithelium in Age-Related Macular Degeneration Using Polarization-Sensitive Optical Coherence TomographyInvestigative Ophthalmology & Visual Science, 2010
- Summary Results and Recommendations From the Age-Related Eye Disease StudyArchives of Ophthalmology (1950), 2009
- Advanced Glycation End Product (AGE) Accumulation on Bruch’s Membrane: Links to Age-Related RPE DysfunctionInvestigative Ophthalmology & Visual Science, 2009
- Antioxidant supplements to prevent or slow down the progression of AMD: a systematic review and meta-analysisEye, 2008
- RPE transplantation and its role in retinal diseaseProgress in Retinal and Eye Research, 2007
- Age‐related macular degeneration—emerging pathogenetic and therapeutic conceptsAnnals of Medicine, 2006
- Improvement in near visual function after macular translocation surgery with 360-degree peripheral retinectomyGraefe's Archive for Clinical and Experimental Ophthalmology, 2004
- Age-Related Macular Degeneration: Etiology, Pathogenesis, and Therapeutic StrategiesSurvey of Ophthalmology, 2003
- Transplantation of autologous retinal pigment epithelium in eyes with foveal neovascularization resulting from age-related macular degeneration: a pilot studyAmerican Journal of Ophthalmology, 2002
- Ageing and degeneration in the macular region: a clinico-pathological study.British Journal of Ophthalmology, 1976